LSPN Connect: Invention harvesting

In the fast-paced environment of life sciences, the need for the IP sector to take full advantage of potential and emerging innovations is paramount, as a LSPN Connect session discovered.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotech

South Korean biotech takes aim at US medtech leader over alleged cell-washing tech theft

13 November 2026 Curiox claims confidential information shared during talks about a potential business partnership was used to develop a competing cell preparation system within months, despite the South Korean company spending years developing its own technology.

Biotech

GSK and Moderna settle cross-border patent dispute over vaccine tech

11 November 2026 The parties granted each other the right to use their respective patented inventions in the field of infectious disease but are not obligated to make any payments in connection with the licences.

Biotech

Regeneron and Amgen call a truce on two Eylea biosimilar patents

28 October 2026 Both companies have agreed to dismiss claims and counterclaims involving Amgen’s 2 mg aflibercept biosimilar, while their wider feud continues.

More features

South Korean biotech takes aim at US medtech leader over alleged cell-washing tech theft

GSK lands 36-country injunction in Pfizer-BioNTech vaccine litigation

‘No medicine is off limits’: US Chamber of Commerce says stricter import rules may deter fakes

GSK and Moderna settle cross-border patent dispute over vaccine tech

Eli Lilly follows Novo in UK High Court bid to block ‘black-market websites’

Irish law firms announce merger

How in-house teams can get more value from external counsel

Regulatory and patent teams must align, say Amgen, Genentech, ORIC

LSPN Connect: Invention harvesting

More on this story

Editor's picks

Editor's picks

More features